2016
DOI: 10.1155/2016/1012847
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson’s Disease

Abstract: Background. MoCA is widely used in Parkinson's disease (PD) to assess cognition. The Test Your Memory (TYM) test is a cognitive screening tool that is self-administered. Objectives. We sought to determine (a) the optimal value of TYM to discriminate between PD patients with and without cognitive deficits on MoCA testing, (b) equivalent MoCA and TYM scores, and (c) interrater reliability in TYM testing. Methods. We assessed the discriminant ability of TYM and the equivalence between TYM and MoCA scores and meas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 22 publications
0
7
0
Order By: Relevance
“…Although James Parkinson initially proposed that PD did not progress to the cerebrum (Parkinson, 2002 ), there is now substantial evidence that PD can compromise higher cortical cognitive processes. The progression may not be the same for all individuals with PD, however; some individuals remain with primary processing-speed impairments while others may present with primary memory impairments and are at greater risk for dementia (Henderson et al, 2016 ; Janvin, Larsen, Aarsland, & Hugdahl, 2006 ). Neuroimaging investigations show regional fractional anisotropy (FA) and volumetric gray and white matter (WM) differences in PD and non-PD peers (Price et al, 2016 ; Tanner et al, 2015 ).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although James Parkinson initially proposed that PD did not progress to the cerebrum (Parkinson, 2002 ), there is now substantial evidence that PD can compromise higher cortical cognitive processes. The progression may not be the same for all individuals with PD, however; some individuals remain with primary processing-speed impairments while others may present with primary memory impairments and are at greater risk for dementia (Henderson et al, 2016 ; Janvin, Larsen, Aarsland, & Hugdahl, 2006 ). Neuroimaging investigations show regional fractional anisotropy (FA) and volumetric gray and white matter (WM) differences in PD and non-PD peers (Price et al, 2016 ; Tanner et al, 2015 ).…”
Section: Introductionmentioning
confidence: 99%
“…In this work, we performed global (average values for the entire brain network for each participant) and local (average values for every individual node for each participant) connectome analyses. Given the elevated risk of developing dementia associated with amnestic mild cognitive impairment in PD (Henderson et al, 2016 ), in this study we examined structural connectome differences in people with PD who are cognitively well relative to individuals with PD who meet criteria for amnestic MCI. We also explored the correlations between topological connectome indices and the most common cognitive vulnerabilities of PD (i.e., processing speed, working memory, and episodic memory; Zgaljardic, Borod, Foldi, & Mattis, 2003 ).…”
Section: Introductionmentioning
confidence: 99%
“…However, administration time is considered a disadvantage of the MoCA (Gill et al, 2008; Roalf et al, 2016; Zadikoff et al, 2008). The standard MoCA takes about 10 to 15 minutes to administer even in the healthy population (Henderson et al, 2016; Kopecek et al, 2017; Roalf et al, 2016) and is approximately two times longer than the administration time of the MMSE (Stepankova et al, 2015). However, recent work has created validated short forms of the MoCA (s-MoCA; Horton et al, 2015; Panenková, Kopeček, & Lukavský, 2016; Roalf et al, 2016).…”
mentioning
confidence: 99%
“…3 To date, only 1 study compared the discriminant validity of the TYM and MoCA, although it was in a Parkinson disease (PD) population. 19 The TYM at its optimal cutoff point (<46) was equivalent to the MoCA (<26) in detecting CI in patients with PD (TYM: sensitivity: 0.91; specificity: 0.59). 19 Our finding that the TYM and the MoCA are equivalent concurs with this study.…”
Section: Discussionmentioning
confidence: 91%